SynthesisPloS one2022

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis.

Shuo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.